Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Contraceptive Drugs and Devices Market Growth 2022-2028

  • LP 4789998
  • 104 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Contraceptive Drugs and Devices will have significant change from previous year. According to our (LP Information) latest study, the global Contraceptive Drugs and Devices market size is USD million in 2022 from USD 6389.6 million in 2021, with a change of % between 2021 and 2022. The global Contraceptive Drugs and Devices market size will reach USD 8746.7 million in 2028, growing at a CAGR of 4.6% over the analysis period.

The United States Contraceptive Drugs and Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Contraceptive Drugs and Devices market, reaching US$ million by the year 2028. As for the Europe Contraceptive Drugs and Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Contraceptive Drugs and Devices players cover Bayer Healthcare, Merck, Church & Dwight, and Warmer Chilcott, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptive Drugs and Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Oral

Vaginal

Injectable Contraceptive Drugs

Male/Female Contraceptive Devices

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospitals

Pharmacies

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bayer Healthcare

Merck

Church & Dwight

Warmer Chilcott

Agile Therapeutics

Pfizer

BioSante Pharmaceuticals

Mayer Laboratories

Pantarhei Bioscience

Teva Pharmaceutical Industries

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Contraceptive Drugs and Devices Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Contraceptive Drugs and Devices by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Contraceptive Drugs and Devices by Country/Region, 2017, 2022 & 2028

2.2 Contraceptive Drugs and Devices Segment by Type

2.2.1 Oral

2.2.2 Vaginal

2.2.3 Injectable Contraceptive Drugs

2.2.4 Male/Female Contraceptive Devices

2.3 Contraceptive Drugs and Devices Sales by Type

2.3.1 Global Contraceptive Drugs and Devices Sales Market Share by Type (2017-2022)

2.3.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Type (2017-2022)

2.3.3 Global Contraceptive Drugs and Devices Sale Price by Type (2017-2022)

2.4 Contraceptive Drugs and Devices Segment by Application

2.4.1 Hospitals

2.4.2 Pharmacies

2.4.3 Others

2.5 Contraceptive Drugs and Devices Sales by Application

2.5.1 Global Contraceptive Drugs and Devices Sale Market Share by Application (2017-2022)

2.5.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Application (2017-2022)

2.5.3 Global Contraceptive Drugs and Devices Sale Price by Application (2017-2022)

3 Global Contraceptive Drugs and Devices by Company

3.1 Global Contraceptive Drugs and Devices Breakdown Data by Company

3.1.1 Global Contraceptive Drugs and Devices Annual Sales by Company (2020-2022)

3.1.2 Global Contraceptive Drugs and Devices Sales Market Share by Company (2020-2022)

3.2 Global Contraceptive Drugs and Devices Annual Revenue by Company (2020-2022)

3.2.1 Global Contraceptive Drugs and Devices Revenue by Company (2020-2022)

3.2.2 Global Contraceptive Drugs and Devices Revenue Market Share by Company (2020-2022)

3.3 Global Contraceptive Drugs and Devices Sale Price by Company

3.4 Key Manufacturers Contraceptive Drugs and Devices Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Contraceptive Drugs and Devices Product Location Distribution

3.4.2 Players Contraceptive Drugs and Devices Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Contraceptive Drugs and Devices by Geographic Region

4.1 World Historic Contraceptive Drugs and Devices Market Size by Geographic Region (2017-2022)

4.1.1 Global Contraceptive Drugs and Devices Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Contraceptive Drugs and Devices Annual Revenue by Geographic Region

4.2 World Historic Contraceptive Drugs and Devices Market Size by Country/Region (2017-2022)

4.2.1 Global Contraceptive Drugs and Devices Annual Sales by Country/Region (2017-2022)

4.2.2 Global Contraceptive Drugs and Devices Annual Revenue by Country/Region

4.3 Americas Contraceptive Drugs and Devices Sales Growth

4.4 APAC Contraceptive Drugs and Devices Sales Growth

4.5 Europe Contraceptive Drugs and Devices Sales Growth

4.6 Middle East & Africa Contraceptive Drugs and Devices Sales Growth

5 Americas

5.1 Americas Contraceptive Drugs and Devices Sales by Country

5.1.1 Americas Contraceptive Drugs and Devices Sales by Country (2017-2022)

5.1.2 Americas Contraceptive Drugs and Devices Revenue by Country (2017-2022)

5.2 Americas Contraceptive Drugs and Devices Sales by Type

5.3 Americas Contraceptive Drugs and Devices Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Contraceptive Drugs and Devices Sales by Region

6.1.1 APAC Contraceptive Drugs and Devices Sales by Region (2017-2022)

6.1.2 APAC Contraceptive Drugs and Devices Revenue by Region (2017-2022)

6.2 APAC Contraceptive Drugs and Devices Sales by Type

6.3 APAC Contraceptive Drugs and Devices Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Contraceptive Drugs and Devices by Country

7.1.1 Europe Contraceptive Drugs and Devices Sales by Country (2017-2022)

7.1.2 Europe Contraceptive Drugs and Devices Revenue by Country (2017-2022)

7.2 Europe Contraceptive Drugs and Devices Sales by Type

7.3 Europe Contraceptive Drugs and Devices Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Contraceptive Drugs and Devices by Country

8.1.1 Middle East & Africa Contraceptive Drugs and Devices Sales by Country (2017-2022)

8.1.2 Middle East & Africa Contraceptive Drugs and Devices Revenue by Country (2017-2022)

8.2 Middle East & Africa Contraceptive Drugs and Devices Sales by Type

8.3 Middle East & Africa Contraceptive Drugs and Devices Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Contraceptive Drugs and Devices

10.3 Manufacturing Process Analysis of Contraceptive Drugs and Devices

10.4 Industry Chain Structure of Contraceptive Drugs and Devices

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Contraceptive Drugs and Devices Distributors

11.3 Contraceptive Drugs and Devices Customer

12 World Forecast Review for Contraceptive Drugs and Devices by Geographic Region

12.1 Global Contraceptive Drugs and Devices Market Size Forecast by Region

12.1.1 Global Contraceptive Drugs and Devices Forecast by Region (2023-2028)

12.1.2 Global Contraceptive Drugs and Devices Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Contraceptive Drugs and Devices Forecast by Type

12.7 Global Contraceptive Drugs and Devices Forecast by Application

13 Key Players Analysis

13.1 Bayer Healthcare

13.1.1 Bayer Healthcare Company Information

13.1.2 Bayer Healthcare Contraceptive Drugs and Devices Product Offered

13.1.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Healthcare Main Business Overview

13.1.5 Bayer Healthcare Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Contraceptive Drugs and Devices Product Offered

13.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Church & Dwight

13.3.1 Church & Dwight Company Information

13.3.2 Church & Dwight Contraceptive Drugs and Devices Product Offered

13.3.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Church & Dwight Main Business Overview

13.3.5 Church & Dwight Latest Developments

13.4 Warmer Chilcott

13.4.1 Warmer Chilcott Company Information

13.4.2 Warmer Chilcott Contraceptive Drugs and Devices Product Offered

13.4.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Warmer Chilcott Main Business Overview

13.4.5 Warmer Chilcott Latest Developments

13.5 Agile Therapeutics

13.5.1 Agile Therapeutics Company Information

13.5.2 Agile Therapeutics Contraceptive Drugs and Devices Product Offered

13.5.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Agile Therapeutics Main Business Overview

13.5.5 Agile Therapeutics Latest Developments

13.6 Pfizer

13.6.1 Pfizer Company Information

13.6.2 Pfizer Contraceptive Drugs and Devices Product Offered

13.6.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Pfizer Main Business Overview

13.6.5 Pfizer Latest Developments

13.7 BioSante Pharmaceuticals

13.7.1 BioSante Pharmaceuticals Company Information

13.7.2 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Offered

13.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 BioSante Pharmaceuticals Main Business Overview

13.7.5 BioSante Pharmaceuticals Latest Developments

13.8 Mayer Laboratories

13.8.1 Mayer Laboratories Company Information

13.8.2 Mayer Laboratories Contraceptive Drugs and Devices Product Offered

13.8.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Mayer Laboratories Main Business Overview

13.8.5 Mayer Laboratories Latest Developments

13.9 Pantarhei Bioscience

13.9.1 Pantarhei Bioscience Company Information

13.9.2 Pantarhei Bioscience Contraceptive Drugs and Devices Product Offered

13.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Pantarhei Bioscience Main Business Overview

13.9.5 Pantarhei Bioscience Latest Developments

13.10 Teva Pharmaceutical Industries

13.10.1 Teva Pharmaceutical Industries Company Information

13.10.2 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Offered

13.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Teva Pharmaceutical Industries Main Business Overview

13.10.5 Teva Pharmaceutical Industries Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Contraceptive Drugs and Devices Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Contraceptive Drugs and Devices Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral

Table 4. Major Players of Vaginal

Table 5. Major Players of Injectable Contraceptive Drugs

Table 6. Major Players of Male/Female Contraceptive Devices

Table 7. Global Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)

Table 8. Global Contraceptive Drugs and Devices Sales Market Share by Type (2017-2022)

Table 9. Global Contraceptive Drugs and Devices Revenue by Type (2017-2022) & ($ million)

Table 10. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2017-2022)

Table 11. Global Contraceptive Drugs and Devices Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)

Table 13. Global Contraceptive Drugs and Devices Sales Market Share by Application (2017-2022)

Table 14. Global Contraceptive Drugs and Devices Revenue by Application (2017-2022)

Table 15. Global Contraceptive Drugs and Devices Revenue Market Share by Application (2017-2022)

Table 16. Global Contraceptive Drugs and Devices Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Contraceptive Drugs and Devices Sales by Company (2020-2022) & (K Units)

Table 18. Global Contraceptive Drugs and Devices Sales Market Share by Company (2020-2022)

Table 19. Global Contraceptive Drugs and Devices Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Contraceptive Drugs and Devices Revenue Market Share by Company (2020-2022)

Table 21. Global Contraceptive Drugs and Devices Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Contraceptive Drugs and Devices Producing Area Distribution and Sales Area

Table 23. Players Contraceptive Drugs and Devices Products Offered

Table 24. Contraceptive Drugs and Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Contraceptive Drugs and Devices Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Contraceptive Drugs and Devices Sales Market Share Geographic Region (2017-2022)

Table 29. Global Contraceptive Drugs and Devices Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Contraceptive Drugs and Devices Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Contraceptive Drugs and Devices Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Contraceptive Drugs and Devices Sales Market Share by Country/Region (2017-2022)

Table 33. Global Contraceptive Drugs and Devices Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Contraceptive Drugs and Devices Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Contraceptive Drugs and Devices Sales by Country (2017-2022) & (K Units)

Table 36. Americas Contraceptive Drugs and Devices Sales Market Share by Country (2017-2022)

Table 37. Americas Contraceptive Drugs and Devices Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Contraceptive Drugs and Devices Revenue Market Share by Country (2017-2022)

Table 39. Americas Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)

Table 40. Americas Contraceptive Drugs and Devices Sales Market Share by Type (2017-2022)

Table 41. Americas Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)

Table 42. Americas Contraceptive Drugs and Devices Sales Market Share by Application (2017-2022)

Table 43. APAC Contraceptive Drugs and Devices Sales by Region (2017-2022) & (K Units)

Table 44. APAC Contraceptive Drugs and Devices Sales Market Share by Region (2017-2022)

Table 45. APAC Contraceptive Drugs and Devices Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Contraceptive Drugs and Devices Revenue Market Share by Region (2017-2022)

Table 47. APAC Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)

Table 48. APAC Contraceptive Drugs and Devices Sales Market Share by Type (2017-2022)

Table 49. APAC Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)

Table 50. APAC Contraceptive Drugs and Devices Sales Market Share by Application (2017-2022)

Table 51. Europe Contraceptive Drugs and Devices Sales by Country (2017-2022) & (K Units)

Table 52. Europe Contraceptive Drugs and Devices Sales Market Share by Country (2017-2022)

Table 53. Europe Contraceptive Drugs and Devices Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Contraceptive Drugs and Devices Revenue Market Share by Country (2017-2022)

Table 55. Europe Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)

Table 56. Europe Contraceptive Drugs and Devices Sales Market Share by Type (2017-2022)

Table 57. Europe Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)

Table 58. Europe Contraceptive Drugs and Devices Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Contraceptive Drugs and Devices Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Contraceptive Drugs and Devices Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Contraceptive Drugs and Devices Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Contraceptive Drugs and Devices

Table 68. Key Market Challenges & Risks of Contraceptive Drugs and Devices

Table 69. Key Industry Trends of Contraceptive Drugs and Devices

Table 70. Contraceptive Drugs and Devices Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Contraceptive Drugs and Devices Distributors List

Table 73. Contraceptive Drugs and Devices Customer List

Table 74. Global Contraceptive Drugs and Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Contraceptive Drugs and Devices Sales Market Forecast by Region

Table 76. Global Contraceptive Drugs and Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Contraceptive Drugs and Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Contraceptive Drugs and Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Contraceptive Drugs and Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Contraceptive Drugs and Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Contraceptive Drugs and Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Contraceptive Drugs and Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Contraceptive Drugs and Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Contraceptive Drugs and Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Contraceptive Drugs and Devices Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Contraceptive Drugs and Devices Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Contraceptive Drugs and Devices Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Contraceptive Drugs and Devices Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Application (2023-2028)

Table 94. Bayer Healthcare Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors

Table 95. Bayer Healthcare Contraceptive Drugs and Devices Product Offered

Table 96. Bayer Healthcare Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Bayer Healthcare Main Business

Table 98. Bayer Healthcare Latest Developments

Table 99. Merck Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors

Table 100. Merck Contraceptive Drugs and Devices Product Offered

Table 101. Merck Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Merck Main Business

Table 103. Merck Latest Developments

Table 104. Church & Dwight Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors

Table 105. Church & Dwight Contraceptive Drugs and Devices Product Offered

Table 106. Church & Dwight Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Church & Dwight Main Business

Table 108. Church & Dwight Latest Developments

Table 109. Warmer Chilcott Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors

Table 110. Warmer Chilcott Contraceptive Drugs and Devices Product Offered

Table 111. Warmer Chilcott Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Warmer Chilcott Main Business

Table 113. Warmer Chilcott Latest Developments

Table 114. Agile Therapeutics Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors

Table 115. Agile Therapeutics Contraceptive Drugs and Devices Product Offered

Table 116. Agile Therapeutics Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Agile Therapeutics Main Business

Table 118. Agile Therapeutics Latest Developments

Table 119. Pfizer Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors

Table 120. Pfizer Contraceptive Drugs and Devices Product Offered

Table 121. Pfizer Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. Pfizer Main Business

Table 123. Pfizer Latest Developments

Table 124. BioSante Pharmaceuticals Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors

Table 125. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Offered

Table 126. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. BioSante Pharmaceuticals Main Business

Table 128. BioSante Pharmaceuticals Latest Developments

Table 129. Mayer Laboratories Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors

Table 130. Mayer Laboratories Contraceptive Drugs and Devices Product Offered

Table 131. Mayer Laboratories Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. Mayer Laboratories Main Business

Table 133. Mayer Laboratories Latest Developments

Table 134. Pantarhei Bioscience Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors

Table 135. Pantarhei Bioscience Contraceptive Drugs and Devices Product Offered

Table 136. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. Pantarhei Bioscience Main Business

Table 138. Pantarhei Bioscience Latest Developments

Table 139. Teva Pharmaceutical Industries Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors

Table 140. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Offered

Table 141. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Teva Pharmaceutical Industries Main Business

Table 143. Teva Pharmaceutical Industries Latest Developments

List of Figures

Figure 1. Picture of Contraceptive Drugs and Devices

Figure 2. Contraceptive Drugs and Devices Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Contraceptive Drugs and Devices Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Contraceptive Drugs and Devices Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Contraceptive Drugs and Devices Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral

Figure 10. Product Picture of Vaginal

Figure 11. Product Picture of Injectable Contraceptive Drugs

Figure 12. Product Picture of Male/Female Contraceptive Devices

Figure 13. Global Contraceptive Drugs and Devices Sales Market Share by Type in 2021

Figure 14. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2017-2022)

Figure 15. Contraceptive Drugs and Devices Consumed in Hospitals

Figure 16. Global Contraceptive Drugs and Devices Market: Hospitals (2017-2022) & (K Units)

Figure 17. Contraceptive Drugs and Devices Consumed in Pharmacies

Figure 18. Global Contraceptive Drugs and Devices Market: Pharmacies (2017-2022) & (K Units)

Figure 19. Contraceptive Drugs and Devices Consumed in Others

Figure 20. Global Contraceptive Drugs and Devices Market: Others (2017-2022) & (K Units)

Figure 21. Global Contraceptive Drugs and Devices Sales Market Share by Application (2017-2022)

Figure 22. Global Contraceptive Drugs and Devices Revenue Market Share by Application in 2021

Figure 23. Contraceptive Drugs and Devices Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Contraceptive Drugs and Devices Revenue Market Share by Company in 2021

Figure 25. Global Contraceptive Drugs and Devices Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Contraceptive Drugs and Devices Revenue Market Share by Geographic Region in 2021

Figure 27. Global Contraceptive Drugs and Devices Sales Market Share by Region (2017-2022)

Figure 28. Global Contraceptive Drugs and Devices Revenue Market Share by Country/Region in 2021

Figure 29. Americas Contraceptive Drugs and Devices Sales 2017-2022 (K Units)

Figure 30. Americas Contraceptive Drugs and Devices Revenue 2017-2022 ($ Millions)

Figure 31. APAC Contraceptive Drugs and Devices Sales 2017-2022 (K Units)

Figure 32. APAC Contraceptive Drugs and Devices Revenue 2017-2022 ($ Millions)

Figure 33. Europe Contraceptive Drugs and Devices Sales 2017-2022 (K Units)

Figure 34. Europe Contraceptive Drugs and Devices Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Contraceptive Drugs and Devices Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Contraceptive Drugs and Devices Revenue 2017-2022 ($ Millions)

Figure 37. Americas Contraceptive Drugs and Devices Sales Market Share by Country in 2021

Figure 38. Americas Contraceptive Drugs and Devices Revenue Market Share by Country in 2021

Figure 39. United States Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Contraceptive Drugs and Devices Sales Market Share by Region in 2021

Figure 44. APAC Contraceptive Drugs and Devices Revenue Market Share by Regions in 2021

Figure 45. China Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Contraceptive Drugs and Devices Sales Market Share by Country in 2021

Figure 52. Europe Contraceptive Drugs and Devices Revenue Market Share by Country in 2021

Figure 53. Germany Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Contraceptive Drugs and Devices Revenue Market Share by Country in 2021

Figure 60. Egypt Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Contraceptive Drugs and Devices Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Contraceptive Drugs and Devices in 2021

Figure 66. Manufacturing Process Analysis of Contraceptive Drugs and Devices

Figure 67. Industry Chain Structure of Contraceptive Drugs and Devices

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390